Anúncio
Anúncio
ABT
Abbott Laboratories
127.92
USDPatrocinado
+1.47
+1.17%
06 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
128.05
+0.13
+0.10%
Relatórios de Lucros ABT
Rácio de surpresa positiva
ABT separação 29 de 39 últimas estimativas.
74%
Próximo Relatório
Data do Próximo Relatório
20 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$11.92B
/$1.51
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+4.87%
/+16.15%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+8.64%
/+12.69%
Abbott Laboratories earnings per share and revenue
On 15 de out. de 2025, ABT reported earnings of 1.30 USD per share (EPS) for Q3 25, missing the estimate of 1.31 USD, resulting in a -1.06% surprise. Revenue reached 11.37 bilhão, compared to an expected 11.52 bilhão, with a -1.30% difference. The market reacted with a -2.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 27 analistas forecast an EPS of 1.51 USD, with revenue projected to reach 11.92 bilhão USD, implying an aumentar of 16.15% EPS, and aumentar of 4.87% in Revenue from the last quarter.
FAQ
What were Abbott Laboratories's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Abbott Laboratories reported EPS of $1.30, missing estimates by -1.06%, and revenue of $11.37B, -1.3% below expectations.
How did the market react to Abbott Laboratories's Q3 2025 earnings?
The stock price moved down -2.87%, changed from $133.27 before the earnings release to $129.45 the day after.
When is Abbott Laboratories expected to report next?
The next earning report is scheduled for 20 de jan. de 2026.
What are the forecasts for Abbott Laboratories's next earnings report?
Based on 27
analistas, Abbott Laboratories is expected to report EPS of $1.51 and revenue of $11.92B for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio